Search results
Will there be a new Covid vaccine in the fall?
NBC NEWS· 3 days agoJN.1 emerged in the U.S. in late August and by January became the dominant strain in circulation. In mid-May, KP.2 ...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
WUSF 89.7· 17 hours agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 5 days agoVaccine makers should consider targeting one of the currently dominant JN.1 variants and...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Reuters via Yahoo News· 1 day agoThe Food and Drug Administration's advisory is in line with European and World Health Organization...
New ‘FLiRT’ COVID Variants Could Be Driving an Uptick in Cases. Here’s How to Avoid Them
Scientific American· 4 days agoCOVID infections in the U.S. have declined since this past winter. The Centers for Disease Control...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
Midland Reporter-Telegram· 3 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
COVID shots should target JN.1 or newer variants in 2024-25 campaign, US FDA advisers say
Reuters· 3 days agoAdvisers to the U.S. Food and Drug Administration on Wednesday unanimously voted in favor of...
FDA advisers: Next COVID shots should target variants with JN.1 lineage | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 4 days agoAdvisers to the U.S. Food and Drug Administration today unanimously voted in favor of recommending...
Novavax Stock Rallies In Pre-Market As Company Plans To Deliver Covid-19 Vaccine By September -...
Benzinga· 2 days agoNovavax revealed that it is on track to deliver a vaccine against a Covid-19 strain recommended by a...
COVID shots should target JN.1 or newer variants in 2024-25 campaign, US FDA advisers say
Reuters via Yahoo News· 3 days ago(Reuters) - Advisers to the U.S. Food and Drug Administration on Wednesday unanimously voted in...